Русский   English

The Nation's Health Institute

Institute Structure
Methods of Treatment
Scientific publications
Scientific Conferences
FAQ
Media about us
Our Partners

Contacts

 

 Nation's Health Institute

   
 
The Nation’s Health Institute was founded on the 20th of April 2004 for coordination
of investigations in the field of medicine and unification of work of scientists and specialists
of different branches of knowledge.

 The main guidelines of Institute activity to date are:

  • research activity in the field of medicine, biology and pharmaceutics;
  • organization and realization of pre-clinical and clinical trials;
  • consultative, diagnostic and medical assistance of doctors-specialists (priority directions: chronic hepatitides, metabolic syndrome, nonspecific ulcerative colitis, diabetes mellitus, rehabilitation of oncologic patients);
  • development and introduction of new medicines, biological active additives and products for special dietary nutrition;
  • development of new methods of treatment and diagnostics of different diseases;
  •  publishing of popular scientific journal “The Nation’s Health”, in which the most interesting materials on health care on the whole and in research areas of the Institute are published.  

INFORMATION FOR VISITORS

Today according to the International Disease Classifier IDC-10, there are more than 12 thousand human diseases in the world, combined into 21 classes. Some of them are striking, widespread and have familiar symptoms. But a great many of diseases can not be revealed quickly and easy, and as everybody knows, early diagnostics of the disease significantly increases chance of recovery and allows to prevent disease transition into chronic stage. At the same time many human diseases even easy recognizable represent serious hidden threat to the mankind. 


Viral and infectious diseases, heart diseases, infarctions, strokes and cancer become more complicated tasks for modern medicine.


Improvement of sanitary conditions and nutrition culture has significant influence on the health of population, as a result infant mortality decreased and more and more people start to live till childbearing age. Thanks to discovery of antibiotics widespread infections, for example, tuberculosis, stopped to threaten the life of people. As a result expected life span increased approximately from 40 years old in XIX century to more than 70 years at present. But spread of diseases the frequency of which is increased with ages became an inevitable consequence of population development and aging.


Every 6th tellurian in any period of his/her life gets cancer disease, 40% of diseased die in the first year after diagnose. According to data of international statistics: today every 72 seconds this disease affects one person, and every 97 seconds one oncological patient dies. Today curability of oncological diseases makes only 26%. As predicted by the International Agency on Cancer Study up to 2015 the planet will be overwhelmed by epidemic of oncological diseases. Every year 15 million of cases will be registered and annually 10 million of patients will die.


What are the main reasons of cancer? If we try to combine all known external factors, provoking cancer (as well as any other malignant tumor), then we will receive extremely simple picture – these are physical factors (ionizing radiation, ultraviolet, etc.), chemical factors (carcinogenic substances) and biological factors (some viruses).


Originally they all result into damage of DNA structure, the consequence of which is usually activation of oncogene and the cell gains “immortality”. There are also internal reasons of cancer. Most often the matter concerns inherited predisposition to cancer. Usually the matter concerns hereditary decrease of ability to DNA recovery, or immunity decrease.


All three methods of treatment are used in cancer treatment: surgical, chemotherapeutical and radial. The choice of treatment method or their combination depends on many factors. As a rule modern surgical treatment is organo-preserving and little-traumatic.  Modern chemotherapeutics as a rule is protocol that allows achieving maximum effect with minimum consequences. Radial influence is used usually in combination with other methods, by strict indications and established protocols. On the whole each kind of cancer requires individual approach to the treatment and its success depends in the first place on the time of detection.


Cancer prophylaxis is directed first of all on revealing pre-cancerous conditions and also on susceptibility to it in order to include patients in risk group. Regular screening investigations should be carried out in risk groups. Thanks to this in Japan, for example, stomach cancer although is revealed approximately 2 times frequently but mortality due to it is 2 times lower than in other countries. 


Cancer is not an inevitability that is why execution of elementary preventive measures decreases risk of disease incidence dozens of times. In common comprehension prophylaxis should be directed on rendering counteraction to cancer development by method of decrease of contact with carcinogens (giving up smoking, normalization of nutrition, etc.), and also improvement of anticancer protection (deactivation of carcinogens, activation of DNA and immunity reparation systems and regular intake of oncoprotectors, especially for risk group).


Theoretically 80% of cancer can be prevented. Pharmacologists all over the world constantly develop new products that are able even not to cure the patient completely then to improve the quality of his/her life for many years, one of such directions – is creation of neoantiogenesis blockers, i.e. substances, able to disturb feeding of cancerous growth.


One of these agents are new «GRINIZATION™» products worked out by World Grinization System Inc., USA  for rehabilitation of oncological patients, for treatment of chronic hepatitides of different etiology and metabolic syndrome.


The Nation’s Health Institute carries out medical and biological maintenance of «GRINIZATION™» program in Ukraine. On the basis of the results of medical investigations reports on «GRINIZATION™» products, they can be recommended for combines use with classic methods of oncology treatment, for use in monotherapy as neoantiogrenesis blockers, and also as oncoprotectors for risk group. 


Chronic viral hepatitides – group of infectious diseases that carry the threat to the mankind not less then cancer. Today in this group of diseases the early diagnostics is also difficult and there are no safe treatment methods. Viral hepatitides B (VHB) and C (VHC) should be emphasized. VHB in most cases has better prognosis of cure, but its prevalence all over the world took huge scales. The share of VHC in incidence is slightly smaller, but we cannot be completely sure of it as this type of hepatitis proceeds insensibly and is called “tender killer” not in vein – liver injury in case of VHC is progressing quickly in outwardly healthy people and often leads to liver cirrhosis or even to hepatocellular carcinoma.


Chronic viral hepatitides due to epidemiology peculiarities affect most frequently young people, many of them in case of absence of adequate treatment die till 40 – 45 years old from liver cirrhosis or cancer. Alcohol, simultaneous infection of several viruses of hepatitis and HIV can speed up the progress of disease.


Thus, acute phase in case of VHC proceeds latently very often, in this case the person does not know for a long period of time about infection up to the moment of significant liver complications or accidental revealing of increased content of liver enzymes in blood or liver increase (by the results of US). The liver itself is the organ that does not respond with pain for occurring pathological processes. Patient with viral hepatitis can feel only undue fatigability, decreased ability to work, etc. for a long period of time whereas liver injury is slowly, gradually, progressing. Due to this reason patients come in view of doctor most often with already formed viral hepatitis or with developed cirrhosis.


Chronic viral hepatitides make up to 70-80% of all hepatitides. Beside viral hepatitides, of great importance are alcohol, toxic, drug-induced hepatitides, especially due to increased for the last time tendency to polypragmasia and uncontrolled intake of medicines by patients. Especially dangerous is combination of these types of hepatitides with viral liver injury.  


Treatment of viral hepatitides is complicated task. Viruses, as it is known, - are intracellular pathogens, which are practically impossible to be influenced by most medicines.  Pathogens of these diseases persist in organism, in addition they are not only in hepatocytes, but also in other cells (for example, in vessels endothelium, kidneys). That is why the problem of viral hepatitides could not be solved even due to liver transplantation – the virus affects donor liver very quickly. Besides there are criteria according to which the necessity of pharmacotherapy and the most rational scheme of treatment are determined. In a number of clinical situations the most expedient is only to observe patients, in other cases it is necessary to start active antiviral treatment.


Rational treatment of chronic viral hepatitides today means the use of interferons and nucleosides analogues. Pegylated interferons – is the largest achievement of the last years in treatment of viral hepatitides. The main contraindications to antiviral therapy are severe accompanying diseases (of cardiovascular system, lungs, kidneys, decompensated diabetes mellitus, psychic disturbances), autoimmune pathology, decompensated liver cirrhosis, drug addiction. The presence of antibodies to microsomes of thyroid gland is the risk factor of further development of thyroid gland dysfunction.


Low efficacy (35-40 % of recovery of patients with VHB and 52 % - with VHC) against the background of great number of severe complications and side effects, and also duration of therapy (from 24 up to 48 weeks and more) together with high cost of pegylated interferons, set the task before the doctors to find more effective, sparing and available for patients methods of treatment of chronic hepatitides.


The scientists of The Nation’s Health Institute, together with the leading patient care institutions in the field of infectious diseases and gastroenterology, introduce new method of treatment of chronic hepatitides of different etiology in Ukraine - «GRINIZATION™». «GRINIZATION™» products have pronounced immunomodulatory and antiviral action with total absence of side effects and contraindications. Duration of therapy makes from 8 up to 16 weeks.


Comparing the results of medical investigation reports the use of «GRINIZATION™» method can be recommended for application in combination with pegylated interferons, to decrease side effects, and also as monotherapy, when interferonotherapy is not prescribed or there is a risk of development of side complications.
For cardiologists the use of «GRINIZATION™» met

hod can be recommended as prophylaxis of atherosclerosis and acute coronary syndrome development, rehabilitation of post-stroke and post-infarction states. The use of method normalizes the following indices: whole protein, protein fractions, complex investigation of lipid metabolism (triglycerides, cholesterol, HDL, LDL, VLDL), C-reactive protein (quantitative method), homocysteine, glycemia level, glucose tolerance test.


At present research on study of method efficacy in case of diabetes mellitus, pancreatitis, nonspecific ulcerative colitis and other autoimmune diseases is carried out.